Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Urokinase receptor forms in serum from non-small cell lung cancer patients: relation to prognosis

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{24e32634e4264f789883e00299e348ca,
title = "Urokinase receptor forms in serum from non-small cell lung cancer patients: relation to prognosis",
abstract = "To study the prognostic impact of the different forms of the receptor for urokinase plasminogen activator (uPAR) in serum from 171 non-small cell lung cancer (NSCLC) patients.",
author = "Almasi, {Charlotte Elberling} and Christensen, {Ib Jarle} and Gunilla H{\o}yer-Hansen and Keld Dan{\o} and Helle Pappot and Hendrik Dienemann and Thomas Muley",
note = "Copyright {\circledC} 2011 Elsevier Ireland Ltd. All rights reserved.",
year = "2011",
month = "12",
doi = "10.1016/j.lungcan.2011.05.008",
language = "English",
volume = "74",
pages = "510--5",
journal = "Lung Cancer",
issn = "0169-5002",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

RIS

TY - JOUR

T1 - Urokinase receptor forms in serum from non-small cell lung cancer patients: relation to prognosis

AU - Almasi, Charlotte Elberling

AU - Christensen, Ib Jarle

AU - Høyer-Hansen, Gunilla

AU - Danø, Keld

AU - Pappot, Helle

AU - Dienemann, Hendrik

AU - Muley, Thomas

N1 - Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

PY - 2011/12

Y1 - 2011/12

N2 - To study the prognostic impact of the different forms of the receptor for urokinase plasminogen activator (uPAR) in serum from 171 non-small cell lung cancer (NSCLC) patients.

AB - To study the prognostic impact of the different forms of the receptor for urokinase plasminogen activator (uPAR) in serum from 171 non-small cell lung cancer (NSCLC) patients.

U2 - 10.1016/j.lungcan.2011.05.008

DO - 10.1016/j.lungcan.2011.05.008

M3 - Journal article

VL - 74

SP - 510

EP - 515

JO - Lung Cancer

JF - Lung Cancer

SN - 0169-5002

IS - 3

ER -

ID: 33271126